Oral Presentation 1 Transplantation for Pediatrics and Benign Diseases Nov. 02 (Fri.) 13:50-15:05 Venue: Room 201 Presenting Order Title Author 1 Shih-Hsiang Chen Clinical Manifestations, Genetic Analysis and Outcome of Transplant-Associated Thrombotic Microangiopathy in Children with Neuroblastoma 2 Venkateswaran Donor Lymphocyte Infusion in children – an ounce V S of prevention provides a pound of cure 3 Yanmin Zhao Salvage Therapy With Dose-Escalating Ruxolitinib As A Bridge To Allogeneic Stem Cell Transplantation For Refractory Hemophagocytic Lymphohistiocytosis 4 Divya Doval Hematopoietic Stem Cell Transplant for Sickle Cell Disease: Single Center Experience from India 5 Lanping Xu Immunosuppressive therapy versus haploidentical transplantation in adults with acquired severe aplastic anaemia
Oral Presentation 2 Cell Therapy and Graft Processing Nov. 02 (Fri.) 13:50-14:55 Venue: Room 102 Presenting Order Title Author 1 Lijuan Ding The Status of CAR-T Cells in vivo from the Perspective of PD-1 Expression and Its Clinical Significance 2 Yasuyuki Arai Myeloid conditioning with c-kit-targeted CAR-T cells enables donor stem cell engraftment without high- dose chemotherapy or radiation 3 Yan Long Scarless correction of Wiskott Aldrich Syndrome patient-specific iPSCs using CRISPR/Cas9 and piggyBac 4 Yan Zhang Allogeneic Hematopoietic Stem Cell Transplantation for Refractory /Relapsed B-Cell Acute Lymphoblastic Leukemia after CART Cell Therapy
Oral Presentation 3 Transplantation for Malignant Diseases Nov. 03 (Sat.) 10:30-12:00 Venue: Room 102 Presenting Order Title Author 1 Bor-Sheng Ko An Artificial Intelligence Approach for Predicting Allogeneic Hematopoietic Stem Cell Transplantation Outcome by Detecting Pre and Post-Transplant Minimal Residual Disease in Acute Myeloid Leukemia Using Flow Cytometry Data 2 Narendra Agrawal Retrospective Study of Philadelphia Positive Acute Lymphoblastic Leukemia – A Single Centre Experience 3 Xiao-Dong Mo, High risk disease status significantly influences the Wei Sun clinical outcomes of acute leukemia patients who experienced relapse and receiving chemotherapy plus donor lymphocyte infusion after haploidentical hematopoietic stem cell transplantation 4 Yanmin Zhao FLT3 -ITD positive is an independent risk factor for adverse outcomes after allogeneic hematopoietic stem cell transplantation in AML 5 Hui-Qiang Huang The benefit of thalidomide maintenance in patients with non-Hodgkin's lymphoma after autologous
stem cell transplantation: a single-center retrospective study 6 Lun-Wei Chiou Stem cell transplantation increases survival probability of patients with multiple myeloma, but may decrease the bortezomib-related survival advantages – an experience in a single institution
Oral Presentation 4 Stem Cell Sources and Stem Cell Biology Nov. 03 (Sat.) 13:00-13:45 Venue: Room 201 Presenting Order Title Author 1 Naoyuki Uchida Total nucleated cell dose less than 2x107/kg in CBT predicts slower engraftment but comparable incidence of neutrophil recovery to those who received ≥2x107/kg 2 Xiaohang Ye, PTPN21, a member of the protein tyrosine Huafang Wang phosphatase family, participates in determining the fate of Human Bone Marrow-DerivedMesenchymal Stem Cells 3 Amir Ali Hamidieh IL-21 Treatment of in vitro Expanded Natural Killer Cell Enhances Its Cytotoxicity Effects against Neuroblastoma Tumor
Oral Presentation 5 Transplantation Complications and Other Issues Nov. 03 (Sat.) 14:15-15:30 Venue: Room 201 Presenting Order Title Author 1 Yuma Tada The influence of cumulative steroid dose on the evaluation of kidney function and sarcopenia index up to 90 days after allogeneic hematopoietic stem cell transplantation 2 Richard Martin Efficacy and Safety of Defibrotide by Veno- occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) Diagnostic Criteria in an Expanded-Access (T-IND) Study 3 Ye Zhao Fecal microbiota transplantation for acute refractory gastrointestinal graft-versus-host disease 4 Monique Jöris Twenty years of haematopoietic stem cell donation in the Asian Pacific region; an overview from the World Marrow Donor Association 5 Feng-Ming Tien Checkpoint blockade with pembrolizumab induce graft-versus-host disease for patients with refractory acute leukemia heavily treated after allogeneic transplantation
Awards Ceremony for Best Abstract Nov. 04 (Sun.) 11:10-12:10 Venue: Room 201 Order Presenting Title Author 1 Vipul Sheth Comparison of FLAMSA based reduced intensity conditioning with Treosulfan/Fludarabine conditioning for patients with acute myeloid leukemia in remission: an ALWP/EBMT analysis. 2 Suradej Hongeng Clinical Outcomes Following LentiGlobin Gene Therapy for Transfusion-Dependent β-Thalassemia in the Northstar HGB-204 Study 3 Yuki Asano-mori Secondary Solid Cancers after Allogeneic Hematopoietic Stem Cell Transplantation: Impact of stem cell source 4 Cong Wei Induction of hematopoietic cells from human embryonic stem cells using self-assembling peptide hydrogel
Nursing (Oral Presentation) Nov. 02 (Fri.) 16:00-17:40 Venue: 3F South Lounge Presenting Order Title Author 1 Meng-Kuan Physical and strength exercise for fatigue Chiang management in hematopoietic stem cell transplantation recipients: A systematic review 2 Jessica Cheng A prospective audit of functional, cognitive, body composition, and nutritional changes during the first 3-months post-allogeneic haematopoietic stem cell transplant (HSCT). 3 Shujia Liu Functional Assessment of Cancer Treatment-the Simplified Chinese Version Translation of the Bone Marrow Transplantation Scale and the Scale's Verification of Reliability and Validity 4 Wenjun Xie Assessment of the quality of life and its related predictors in acute leukemia patients early after hematopoietic stem cell transplantation 5 Ayako Mori The program evaluation of education workshops for LTFU outpatient care nurse between 2012 and 2017 in Japan
Recommend
More recommend
